Dr. William F. Schmalz Jr., MD

Dr. Schmalz practices at Skilled Facility Health Care Solutions Inc in La Crescenta, California.

Dr. Schmalz's NPI, 1689852428, was assigned on February 4, 2008. Dr. Schmalz graduated from St. George's University School of Medicine in 2004. Dr. Schmalz's New Jersey license number on file is 25MA0342000.

Dr. Schmalz's primary practice is Skilled Facility Health Care Solutions Inc, at 3747 Foothill Blvd, La Crescenta, CA 91214 in Los Angeles County. The practice phone is (310) 445-5999.

Dr. Schmalz's primary practice is Skilled Facility Health Care Solutions Inc in La Crescenta, California. The medical group on file is Skilled Physicians Group. Dmand AI also links Dr. Schmalz to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schmalz practices, 3 sites in all. Vendor and product names are available with a free account.

General practice is Dr. Schmalz's primary specialty in the NPI Registry, under taxonomy code 208D00000X. Dmand AI has Dr. Schmalz's licenses on file in 3 states: New Jersey, Florida and New York.

CMS data shows 5,179 Medicare services from Dr. Schmalz across 15 procedure codes in 2024, for 1,020 Medicare patients. Medicare paid $579,253 for them. Every service was in an office.

CMS counts 1,020 Medicare patients who saw Dr. Schmalz in 2024. The largest group is 85 and over, with 416 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 48% are also on Medicaid. Their average risk score is 2.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schmalz's median patient age at 68, with 63% women.

In 2024, Dr. Schmalz wrote 181 Medicare Part D claims for 70 patients. 94% of them were for generic drugs. CMS names the drug for 27 of them, across 2 drugs with 11 or more claims each, at $66 in total drug cost. In 2019, CMS named 146 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Schmalz for performance year 2024, reported as part of a group. Dr. Schmalz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 256 procedures of removal of tissue by Dr. Schmalz, more than 93% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 34 general payments to Dr. Schmalz from 11 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $167.

Dmand AI lists 2 awards for Dr. Schmalz, most recently NCQA PCMH in 2012.

Dr. Schmalz graduated from St. George's University School of Medicine in 2004.

Dr. Schmalz is in network with 4 carriers, including Aetna, Elevance and CMS Medicare. EPO plans come from the most carriers, 2. Check the plan with the practice before a visit.